Subscribe: Markets,,3_7031,00.xml&author=Wall%20Street%20Journal&title=Market%20News
Added By: Feedage Forager Feedage Grade B rated
Language: English
air products  business  chinese  copper  fannie  freddie  gilead  great  investors  markets  products bid  products  question  tesla  trump 
Rate this Feed
Rate this feedRate this feedRate this feedRate this feedRate this feed
Rate this feed 1 starRate this feed 2 starRate this feed 3 starRate this feed 4 starRate this feed 5 star

Comments (0)

Feed Details and Statistics Feed Statistics
Preview: Markets Markets


Last Build Date: Wed, 22 Feb 2017 03:26:55 EST

Copyright: copyright © 2017 Dow Jones & Company, Inc.

Air Products Bid for Chinese Rival Has Investors Pumped

Tue, 21 Feb 2017 22:16:51 EST

Air Products bid for Yingde Gases is a major test of U.S.-Chinese cross border investing.

The Great Mystery Behind Tesla's Rally

Tue, 21 Feb 2017 15:51:30 EST

Tesla investors are ignoring significant risks ahead of Wednesday’s earnings report, the first to reflect results from SolarCity.

Gilead Goes to the Head of the Line

Tue, 21 Feb 2017 13:04:57 EST

Gilead Sciences’s approach to the biotech deals market involves more than just waiting.

HSBC Feels Chill Wind From Trump on Trade

Tue, 21 Feb 2017 07:59:51 EST

For a bank that says it generates nearly half its revenue from business that crosses international borders, protectionism and populism are clearly a threat.

Government Wins Flexibility on Fannie and Freddie

Tue, 21 Feb 2017 16:35:30 EST

A major court ruling underscores that what to do with Fannie Mae and Freddie Mac is a political question.

Economy Up, Stocks Down? Don't Be Surprised

Tue, 21 Feb 2017 09:19:58 EST

Investors bullish about a Trump capital expenditure boom must realize that buybacks, one of the bull market’s drivers, may suffer.

BHP: Watch Flip Side of Mining Giant's Copper Surge

Tue, 21 Feb 2017 04:35:43 EST

BHP’s concentration on copper paid off in 2016, but the easy part is over.

Alzheimer's: Pharma's Great White Whale Is Still Worth Hunting

Mon, 20 Feb 2017 09:03:04 EST

The drug industry has had multiple expensive failures trying to treat Alzheimer’s disease, yet the big potential payoff keeps it searching.

What's Lurking in Credit Suisse's Fat Margins

Mon, 20 Feb 2017 14:02:15 EST

The Swiss bank’s wealth business is doing better than rivals, though investors should question its sustainability.